QMSMEDI150.00

QMS Medical Allied Services Limited

· Pharma & Health
AnnualQuarterly₹ CroreMcap ₹290 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations88.446.591.237.381.756.9
Other Income1.30.30.50.30.50.4
Total Income89.746.891.737.682.257.3
Expenses
+ Purchases of Stock-in-Trade43.727.854.824.445.330.1
+ Changes in Inventories1.5-1.9-3.3-5.5-4.2-3.9
+ Employee Benefit Expense5.43.36.33.08.911.2
+ Finance Costs2.71.42.81.73.81.7
+ Depreciation & Amortisation2.20.91.81.02.11.5
+ Other Expenses24.610.820.08.619.211.2
Total Expenses80.142.382.433.375.151.7
EBITDA13.36.413.46.712.58.3
EBIT11.15.611.65.710.46.8
Profit
PBT before Exceptional Items9.74.59.34.37.15.5
Pretax Income9.74.59.34.37.15.5
+ Current Tax3.11.12.31.12.41.3
+ Deferred Tax-0.50.30.30.0-0.40.3
Tax Expense2.61.32.61.11.91.6
+ Share of Associates & JVs0.02.90.00.00.00.0
Net Income7.16.36.73.25.24.0
+ Net Income — Continuing Ops4.0
+ Other Comprehensive Income-0.0
Total Comprehensive Income3.9
Net Income to Common3.6
Minority Interest0.3
Per Share
Basic EPS3.511.643.321.242.112.05
Diluted EPS3.511.643.321.242.112.05
Profit Build-up — Alternate / Pre-Ind-AS Tags
PBT before Exceptional & Extraordinary Items9.74.59.34.37.1
+ Adjustments to Profit / (Loss)2.2
Profit for the Period before Minority Interest7.13.26.73.25.2
+ Minority Interest0.00.20.00.00.0
Continuing & Discontinued Operations
Profit from Continuing Operations7.13.26.73.25.2
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.0
+ Items NOT to be Reclassified to P&L-0.0
+ Tax on Items NOT to be Reclassified-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations2.05
Diluted EPS — Continuing Operations2.05
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit43.320.639.718.440.630.7
Gross Margin %48.9344.2343.5349.3749.6553.97
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)9.74.59.34.37.15.5
Net Income Adj (tax-effected)7.16.36.73.25.24.0
EPS Adj3.511.643.321.242.112.05
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.0010.0010.00
Filed Debt Equity0.000.000.000.00
Filed Dscr0.010.010.030.02
Filed Iscr0.050.040.080.05
Paid Up Equity Capital17.917,85,000.019.319.319.319.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.